Literature DB >> 8939193

Inclusion body myositis, a review.

S Carpenter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8939193     DOI： 10.1097/00005072-199611000-00001

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN： 0022-3069            Impact factor:   3.685


× No keyword cloud information.
  6 in total

1.  Inclusion Body Myositis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-01       Impact factor: 3.598

2.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

3.  Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.

Authors:  K Fukuchi; D Pham; M Hart; L Li; J R Lindsey
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

4.  Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle.

Authors:  Alexander Shtifman; Christopher W Ward; Derek R Laver; Mark L Bannister; Jose R Lopez; Masashi Kitazawa; Frank M LaFerla; Noriaki Ikemoto; Henry W Querfurth
Journal:  Neurobiol Aging       Date:  2008-12-23       Impact factor: 4.673

Review 5.  Theories of the pathogenesis of inclusion body myositis.

Authors:  Steven A Greenberg
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.686

6.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.